Chargement en cours...
Pharmacokinetic study of the oral fluorouracil antitumor agent S‐1 in patients with impaired renal function
Although dose reduction of S‐1 is recommended for patients with impaired renal function, dose modification for such patients has not been prospectively evaluated. The aim of the present study was to investigate the pharmacokinetic parameters of 5‐fluorouracil, 5‐chloro‐2,4 dihydroxypyridine and oter...
Enregistré dans:
| Publié dans: | Cancer Sci |
|---|---|
| Auteurs principaux: | , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6550132/ https://ncbi.nlm.nih.gov/pubmed/30989775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14025 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|